HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Morbidity from hemoblastosis in the Rovenskiĭ district of Ukraine before and after the accident at the Chernobyl Nuclear Power Station].

Abstract
Hemoblastosis morbidity in children and adult populations and its structure were studied during the period of 1981-1992 at Rovensky district of Ukraine, 6 northern districts of which were affected by radionuclides after Chernobyl AES accident. Primary documentation, actual and archival records were the object of study: registration diaries, records and ambulatory cards. Expeditional method of investigation. During the last 11 years a rise of hemoblastosise morbidity was stated in Rovensky district, especially after the accident, and it was confirmed by a profound statistical analysis of data on leukemia morbidity before and after the accident. Among different nosological forms after the accident the rate of leukemia morbidity as well as myeloma disease and malignant lymphoma morbidity, rose markedly. No significant difference was marked in hemoblastoses (excluding acute leukemia) in non-contaminated and contaminated with radionuclides regions of the district, and in contaminated zones depending on effective equivalent doze. Acute leukemia morbidity in contaminated regions after the accident was statistically reliably higher.
AuthorsIa I Vygovskaia, B V Kachorovskiĭ, A A Mazurok, L M Lukavetskiĭ, V V Orlik
JournalGematologiia i transfuziologiia (Gematol Transfuziol) 1994 May-Jun Vol. 39 Issue 3 Pg. 22-4 ISSN: 0234-5730 [Print] Russia (Federation)
Vernacular TitleZabolevaemost' gemoblastozami v Rovenskoĭ oblasti Ukrainy do i posle avarii na Chernobyl'skoĭ AES.
PMID8076787 (Publication Type: English Abstract, Journal Article)
Topics
  • Accidents
  • Adult
  • Child
  • Humans
  • Leukemia, Radiation-Induced (epidemiology)
  • Neoplasms, Radiation-Induced (epidemiology)
  • Nuclear Reactors
  • Retrospective Studies
  • Ukraine (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: